Roches CEO Thomas Schinecker says the companys portfolio of obesity drugs, and those that counter the side effects of weight loss, will help it stand







Roche's weight loss adjacent drugs will boost its competitiveness, CEO says [-bhJ1BHYmNB]

Roche's weight loss adjacent drugs will boost its competitiveness, CEO says [-bhJ1BHYmNB]

| 1h 28m 28s | Video has closed captioning.

Roche's CEO Thomas Schinecker says the company's portfolio of obesity drugs, and those that counter the side effects of weight loss, will help it stand out in the increasingly competitive market.

Aired: December 12, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of Roche's weight loss adjacent drugs will boost its competitiveness, CEO says [-bhJ1BHYmNB] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into Roche's weight loss adjacent drugs will boost its competitiveness, CEO says [-bhJ1BHYmNB] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how Roche's weight loss adjacent drugs will boost its competitiveness, CEO says [-bhJ1BHYmNB] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now